Vaccines became a hot button issue during the height of the COVID-19 pandemic — a polarizing point of contention. And now, it appears that anti-vaccine sentiments have spilled over to all kinds of immunizations, including those required for kids to attend school.
Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall Street analysts are betting on a 2027 list that will include Ozempic.
The study in JAMA Network Open is the first to mine WHO's global database of suspected drug side effects for reports of suicidal thinking in patients who have taken the drugs.